Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination-Reference-Cited by-同舟云学术

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Lövgren Tanja¹²^ORCID,Wolodarski Maria¹,Wickström Stina¹^ORCID,Edbäck Ulrika¹,Wallin Mette³,Martell Eva⁴,Markland Katrin⁵,Blomberg Pontus⁵,Nyström Maria¹,Lundqvist Andreas¹^ORCID,Jacobsson Hans⁶,Ullenhag Gustav²⁷,Ljungman Per⁴⁸,Hansson Johan¹,Masucci Giuseppe¹^ORCID,Tell Roger¹,Poschke Isabel¹⁹^ORCID,Adamson Lars¹,Mattsson Jonas¹¹⁰^ORCID,Kiessling Rolf¹^ORCID

Affiliation:

1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

2. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

3. Center for Clinical Cancer Studies, Karolinska University Hospital Solna, Stockholm, Sweden

4. Center for Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden

5. Vecura, Karolinska Cell Therapy Center, Karolinska University Hospital Huddinge, Stockholm, Sweden

6. Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital Solna, Stockholm, Sweden

7. Department of Oncology, Uppsala University Hospital, Uppsala, Sweden

8. Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

9. DKTK Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany

10. Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network, University of Toronto, Toronto, Canada

Funder

Rolf Kiessling from the Swedish Cancer Society

Cancer Society in Stockholm

Swedish Medical Research Council

Stockholm City Council

“Knut and Alice Wallenberg Foundation”

“Torsten Söderbergs Stiftelse”

Pontus Blomberg from the Swedish Governmental Agency for Innovation Systems

Swedish Foundation for Strategic Research

Publisher

Informa UK Limited

Subject